Citrullinated antibodies in systemic lupus erythematosus and primary Sjogren's syndrome

被引：0

作者：

Hullo, D. ^{[1
]}

Szoeke, L. ^{[2
]}

Szollosl, I ^{[3
]}

Balog, A. ^{[1
]}

Sonkodi, G. ^{[1
]}

Lele, K. ^{[1
]}

Torok, E. ^{[3
]}

Kovacs, L. ^{[1
]}

Zeher, M. ^{[3
]}

Sipka, S. ^{[3
]}

Pokorny, G. ^{[1
]}

机构：

[1] Univ Szeged, Dept Rheumatol, Szeged, Hungary

[2] Univ Szeged, Dept Clin Chem, Szeged, Hungary

[3] Univ Debrecen, Dept Internal Med 3, Debrecen, Hungary

来源：

2ND EUROPEAN CONGRESS OF IMMUNOLOGY (ECI) | 2009年

关键词：

EROSIVE ARTHRITIS; REVISED CRITERIA; PEPTIDE; CLASSIFICATION;

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Although anti-cyclic-citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) antibodies are highly sensitive scrological markers for the diagnosis of rheumatoid arthritis (RA). These antibodies can also occur in systemic lupus erythematosus (SLF) and in primary Sjogren's syndrome (SS). Of our 115 SLF patients. 21 (18.3%) were anti-MCV and 10(8.7%) anti-CCP positive. Of the 68 SS patients. 10 (14.7%) were anti-MCV and 7 (10.3%) anti-CCP positive. No correlation was observed between the antibody positivity and the organ manifestations. In the 139 RA control patients. anti-CCP positivity was more common (108/139) than anti-MCV positivity (92/139).

引用

页码：309 / +

页数：3

共 50 条

[1] Systemic lupus erythematosus and Sjogren's syndrome
Tsokos, GC
[J]. CURRENT OPINION IN RHEUMATOLOGY, 2005, 17 (05) : 511 - 512
[2] COGNITIVE DYSFUNCTION IN PRIMARY SJOGREN'S SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS
Garza Martinez, M. J.
Trevino-Castro, M. A.
Hernandez-Galarza, I. D. J.
Cardenas, A.
Pineda, R.
Solis, C. V.
Riegatorres, J. C.
Skinner Taylor, C. M.
Galarza-Delgado, D. A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1501 - 1502
[3] Systemic lupus erythematosus and Sjogren's syndrome
Diamond, Betty
[J]. CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (05) : 405 - 405
[4] Paraneoplastic associated antineuronal antibodies in patients with primary Sjogren's syndrome or systemic lupus erythematosus.
Benyahia, B
Amoura, Z
Rousseau, A
Leclanche, C
Carpentier, A
Piette, JC
Delattre, JY
[J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S205 - S205
[5] Use of methotrexate in patients with systemic lupus erythematosus and primary Sjogren's syndrome
Winzer, M.
Aringer, M.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S156 - S159
[6] Sjogren's syndrome associated with systemic lupus erythematosus
Tasdemir, Mehmet
Hasan, Chiar
Agbas, Ayse
Kasapcopur, Ozgur
Canpolat, Nur
Sever, Lale
Caliskan, Salim
[J]. TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2016, 51 (03): : 166 - 168
[7] Secondary Sjogren's syndrome in systemic lupus erythematosus
Makula, E.
Fejes, I.
Kiss, M.
Nyari, T.
Bocskai, M.
Kardos, L.
Husz, S.
Janaky, M.
Pokorny, G.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 471 - 471
[8] Genetics of systemic lupus erythematosus and Sjogren's syndrome
Scofield, R. Hal
[J]. CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (05) : 448 - 453
[9] Sjogren's syndrome associated with systemic lupus erythematosus - Clinical and laboratory profiles and comparison with primary Sjogren's syndrome
Manoussakis, MN
Georgopoulou, C
Zintzaras, E
Spyropoulou, M
Stavropoulou, A
Skopouli, FN
Moutsopoulos, HM
[J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (03): : 882 - 891
[10] Systemic lupus erythematosus and Sjogren syndrome
Diamond, Betty
[J]. CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (05) : 449 - 450

← 1 2 3 4 5 →